Curaleaf Holdings (CURLF) Selling, General & Administrative (2019 - 2026)
Curaleaf Holdings (CURLF) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn | 131.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 131.68 Mn |
| Mar 31, 2026 | 113.21 Mn |
| Dec 31, 2025 | 105.76 Mn |
| Sep 30, 2025 | 110.18 Mn |
| Jun 30, 2025 | 105.22 Mn |
| Mar 31, 2025 | 106.19 Mn |
| Dec 31, 2024 | 98.34 Mn |
| Sep 30, 2024 | 106.30 Mn |
| Jun 30, 2024 | 109.51 Mn |
| Mar 31, 2024 | 104.39 Mn |
| Dec 31, 2023 | 98.46 Mn |
| Sep 30, 2023 | 97.12 Mn |
| Jun 30, 2023 | 108.71 Mn |
| Dec 31, 2022 | 120.83 Mn |
| Sep 30, 2022 | 101.73 Mn |
| Jun 30, 2022 | 107.78 Mn |
| Dec 31, 2021 | 103.88 Mn |
| Sep 30, 2021 | 101.80 Mn |
| Jun 30, 2021 | 87.96 Mn |
| Mar 31, 2021 | 80.09 Mn |